Global Point-of-care Molecular Diagnostic Solution Market Growth (Status and Outlook) 2023-2029

Global Point-of-care Molecular Diagnostic Solution Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Point-of-care Molecular Diagnostic Solution Industry Forecast” looks at past sales and reviews total world Point-of-care Molecular Diagnostic Solution sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-care Molecular Diagnostic Solution sales for 2023 through 2029. With Point-of-care Molecular Diagnostic Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Molecular Diagnostic Solution industry.

This Insight Report provides a comprehensive analysis of the global Point-of-care Molecular Diagnostic Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Molecular Diagnostic Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Point-of-care Molecular Diagnostic Solution market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Molecular Diagnostic Solution and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Molecular Diagnostic Solution.

The global Point-of-care Molecular Diagnostic Solution market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Point-of-care Molecular Diagnostic Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Point-of-care Molecular Diagnostic Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Point-of-care Molecular Diagnostic Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Point-of-care Molecular Diagnostic Solution players cover Abbott Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories, Inc., Cepheid, Inc., Danaher Corporation, Johnson and Johnson and Bayer Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Molecular Diagnostic Solution market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Assays & kits
Instruments & Analyzers
Software & Services

Segmentation by application
Physicians’ Offices
Hospitals & ICUs
Research Institutes
Other End Users

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Danaher Corporation
Johnson and Johnson
Bayer Healthcare

Please note: The report will take approximately 2 business days to prepare and deliver.